Court sides with Amgen in Enbrel biosimilar patent case BioPharma-Reporter.com
The US District Court for the District of New Jersey ruled in Amgen’s favor on the validity of the two patents on Enbrel and the methods for making it. Immunex …
Court sides with Amgen in Enbrel biosimilar patent case BioPharma-Reporter.com
The US District Court for the District of New Jersey ruled in Amgen’s favor on the validity of the two patents on Enbrel and the methods for making it. Immunex …